Page 51 - Exact Sciences News Today

Financial Times: Companies claim they can analyse DNA to find the disease early.

Bill Ackman recently revealed a $1 billion bet on Google parent Alphabet, while Stanley Druckenmiller pumped a combined $430 million into Microsoft and Nvidia.

Analysts’ new coverage for Thursday, May 18th: StockNews.com initiated coverage on shares of Agilent Technologies (NYSE:A). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Alcoa (NYSE:AA). They issued a sell rating on the stock. StockNews.com began coverage on shares of American Airlines Group (NASDAQ:AAL). StockNews.com issued a buy […]

Exact Sciences makes molecular diagnostic tests for the early detection of colorectal and other cancers. Its flagship product is Cologuard, a stool-ba

Exact Sciences (NASDAQ:EXAS – Get Rating) had its target price raised by Piper Sandler from $70.00 to $80.00 in a report issued on Monday, The Fly reports. Piper Sandler’s price target would indicate a potential upside of 0.08% from the company’s previous close. EXAS has been the subject of a number of other research reports. […]

A team of researchers from the Center for Plant Protein Research (CIProVe) and the Center for Research and Development in Applied Sciences Dr. Jorge J. Ronco (Cindeca), both from the School of Exact Sciences of the National University of La Plata (UNLP) announced that the fungus Candida antarctica has a series of properties that make the manufacture of Ibuprofen more efficient, Diario Hoy reported.

Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ:EXAS) saw its shares spike over 17% on its Q1 2023 earnings results.

Exact Sciences will look to leverage AI to revolutionize its industry. Here are some other Cathie Wood AI stocks to consider too.

Principal Financial Group Inc. lifted its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 1,999.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 866,805 shares of the medical research company’s stock after purchasing an additional 825,515 shares during the […]

Eau Claire Leader-Telegram. May 14, 2023.